{"nct_id":"NCT02464228","title":"Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy","status":"COMPLETED","status_verified_date":"2024-04","start_date":"2016-02-25","start_date_type":"ACTUAL","primary_completion_date":"2021-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-31","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["KURA"]}